DNA-Guided cancer treatment trial seeks to match patients with therapy
NCT ID NCT04273061
Summary
This study is testing whether a cancer drug called atezolizumab works better when given to people whose tumor DNA analysis suggests they might respond to it. It will enroll about 200 adults with various advanced, incurable solid tumors. Participants will receive the drug every three weeks and doctors will track if their cancer shrinks or stabilizes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
BC Cancer
RECRUITINGVancouver, British Columbia, V5Z 4E6, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University Health Network / Princess Margaret Cancer Centre
WITHDRAWNToronto, Ontario, M5G 2M9, Canada
Conditions
Explore the condition pages connected to this study.